Journal Title：Molecular & Cellular Proteomics

The mission of MCP is to foster the development and applications of proteomics in both basic and translational research. MCP will publish manuscripts that report significant new biological or clinical discoveries underpinned by proteomic observations across all kingdoms of life. Manuscripts must define the biological roles played by the proteins investigated or their mechanisms of action.

The journal also emphasizes articles that describe innovative new computational methods and technological advancements that will enable future discoveries. Manuscripts describing such approaches do not have to include a solution to a biological problem, but must demonstrate that the technology works as described, is reproducible and is appropriate to uncover yet unknown protein/proteome function or properties using relevant model systems or publicly available data.

Scope:

-Fundamental studies in biology, including integrative "omics" studies, that provide mechanistic insights

-Novel experimental and computational technologies

-Proteogenomic data integration and analysis that enable greater understanding of physiology and disease processes

-Pathway and network analyses of signaling that focus on the roles of post-translational modifications

-Studies of proteome dynamics and quality controls, and their roles in disease

-Studies of evolutionary processes effecting proteome dynamics, quality and regulation

-Chemical proteomics, including mechanisms of drug action

-Proteomics of the immune system and antigen presentation/recognition

-Microbiome proteomics, host-microbe and host-pathogen interactions, and their roles in health and disease

-Clinical and translational studies of human diseases

-Metabolomics to understand functional connections between genes, proteins and phenotypes

MCP 的使命是促進蛋白質(zhì)組學在基礎研究和轉(zhuǎn)化研究中的發(fā)展和應用。MCP 將發(fā)表報告所有生命界蛋白質(zhì)組學觀察結(jié)果所支持的重大新生物學或臨床發(fā)現(xiàn)的稿件。稿件必須定義所研究蛋白質(zhì)所起的生物學作用或其作用機制。

該期刊還強調(diào)描述創(chuàng)新的新計算方法和技術(shù)進步的文章，這些方法和技術(shù)進步將推動未來的發(fā)現(xiàn)。描述此類方法的稿件不必包含生物學問題的解決方案，但必須證明該技術(shù)按所述方式工作、可重復并且適合使用相關(guān)模型系統(tǒng)或公開數(shù)據(jù)揭示尚未發(fā)現(xiàn)的蛋白質(zhì)/蛋白質(zhì)組功能或特性。

范圍：

-生物學基礎研究，包括綜合“組學”研究，提供機制見解

-新穎的實驗和計算技術(shù)

-蛋白質(zhì)組學數(shù)據(jù)整合和分析，使人們能夠更好地了解生理學和疾病過程

-信號通路和網(wǎng)絡分析，重點關(guān)注翻譯后修飾的作用

-蛋白質(zhì)組動力學和質(zhì)量控制研究及其在疾病中的作用

-影響蛋白質(zhì)組動力學、質(zhì)量和調(diào)控的進化過程研究

-化學蛋白質(zhì)組學，包括藥物機制作用

-免疫系統(tǒng)的蛋白質(zhì)組學和抗原呈遞/識別

-微生物組蛋白質(zhì)組學、宿主-微生物和宿主-病原體相互作用及其在健康和疾病中的作用

-人類疾病的臨床和轉(zhuǎn)化研究

-代謝組學以了解基因、蛋白質(zhì)和表型之間的功能聯(lián)系

Molecular & Cellular Proteomics創(chuàng)刊于2002年，由American Society for Biochemistry and Molecular Biology Inc.出版商出版，收稿方向涵蓋生物 - 生化研究方法全領(lǐng)域，此刊是該細分領(lǐng)域中屬于非常不錯的SCI期刊，在行業(yè)細分領(lǐng)域中學術(shù)影響力較大，專業(yè)度認可很高，所以對原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 約3.0個月 ，影響因子指數(shù)6.1，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。